SymBio Pharmaceuticals Ltd

4582.T-JP:Tokyo Stock Exchange
*Data is delayed | JPY
Last | 3:00 PM JST
496.00quote price arrow up+35.00 (+7.59%)
Volume
2,270,000
52 week range
243.00 - 653.00

...

Loading . . .

KEY STATS

  • Open459.00
  • Day High498.00
  • Day Low458.00
  • Prev Close461.00
  • 52 Week High653.00
  • 52 Week High Date01/15/20
  • 52 Week Low243.00
  • 52 Week Low Date03/13/20
  • Market Cap147.49M
  • Shares Out35.17M
  • 10 Day Average Volume1.62M
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change-22.98

RATIOS/PROFITABILITY

  • EPS (TTM)-104.20
  • P/E (TTM)-4.76
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest SymBio Pharmaceuticals Ltd News

There is no recent news for this security.

Latest 4582.T-JP News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
SymBio Pharmaceuticals Limited is a Japan-based pharmaceutical company. Along with medicine specialists, contract research organizations (CROs) and other pharmaceutical companies, the Company is engaged in the design and operation of clinical tests, the manufacture and sale of new drugs specializing in three therapeutic areas: cancer, blood diseases and autoimmune diseases. The Company develops new medicines using chemical compounds proofed by preclinical tests and clinical...
Fuminori Yoshida
Chief Executive Officer
Takaaki Fukushima
Chief Financial Officer
Address
Toranomon 30 Mori Bldg.
3-2-2, Toranomon
Minato-ku, TKY
105-0001
Japan